Benjamin Derman

38PUBLICATIONS

147CO-AUTHORS

Gene and molecular therapyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceMedical biotechnology diagnostics (incl. biosensors)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (38)

Sort by Publication Date:

|May 27, 2026

Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

|May 20, 2026

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

|Apr 28, 2026

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.

|Apr 10, 2026

Remote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic Malignancies.

Benjamin A Derman, James H Essell, Mustafa S Ascha

|Jan 21, 2026

Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Melissa Alsina, Nina Shah, Sundar Jagannath

|Jan 06, 2026

Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.

Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi

Pageof 7

Frequent Collaborators

Andrzej Jakubowiak

Tadeusz Kubicki

Andrew T Stefka

Shaji Kumar

Rahul Banerjee

Hira Mian

Anna Pula

Luciano J Costa

Jesus G Berdeja

Krzysztof Jamroziak

Frequent Collaborators

Andrzej Jakubowiak

Tadeusz Kubicki

Andrew T Stefka

Shaji Kumar